The effect of vitamin A in the treatment of idiopathic persistent microscopic hematuria in children 5 to 12 years old

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014091013366N3

Enrollment

152

Registered

2014-11-08

Start date

2013-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic persistent microscopic hematuria. Unspecified haematuria

Interventions

Intervention 1: Groups Case: patients in addition to vitamin A description of the two kinds of pearl is given for 14 days. Intervention 2: Groups control : patients without vitamin A description shoul

Treatment - Drugs

Groups Case: patients in addition to vitamin A description of the two kinds of pearl is given for 14 days

Groups control : patients without vitamin A description should be given notice of the recipients.

Eligibility

Sex/Gender

All

Age

5 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: all children aged between 5 to 12 years old with idiopathic microscopic hematuria diagnosed by the Executive consistently been the cause of hematuria was found during the survey. Exclusion criteria: all patients whose parents did not agree to participate; patients with renal anomalies; the use of certain drugs cause hematuria within 4 reviews

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Urine analysis. Timepoint: 3 urine test within 14 days. Method of measurement: urine.	—

Secondary

Measure	Time frame
Urine culture - the ratio of calcium to creatinine. Timepoint: First time in 14 days. Method of measurement: Urine tests - ultrasound.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026